dipyridamole has been researched along with Abnormality, Heart in 13 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Optimum drug or combination of drugs and dosage are still controversial." | 1.26 | [Inhibition of platelet function in pediatric medicine (author's transl)]. ( Schmidt, B, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (61.54) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KOBAYASHI, T | 1 |
| TAKEUCHI, M | 1 |
| Agarwal, KC | 1 |
| Wahner, HW | 1 |
| Dewanjee, MK | 1 |
| Fuster, V | 1 |
| Puga, FJ | 1 |
| Danielson, GK | 1 |
| Chesebro, JH | 1 |
| Feldt, RH | 1 |
| Willoughby, ML | 1 |
| Schmidt, B | 2 |
| Fiane, AE | 1 |
| Seem, E | 1 |
| Geiran, O | 1 |
| Lindberg, HL | 1 |
| Malouf, JF | 1 |
| Alam, S | 1 |
| Gharzeddine, W | 1 |
| Stefadouros, MA | 1 |
| Ivy, DD | 2 |
| Kinsella, JP | 2 |
| Ziegler, JW | 2 |
| Abman, SH | 2 |
| Wiggins, JW | 1 |
| Reller, MD | 1 |
| Sutor, H | 1 |
| Lorenz, H | 1 |
| Nuutinen, LS | 1 |
| Mononen, P | 1 |
| Hilger, H | 1 |
| Behrenbeck, D | 1 |
| Hellivig, H | 1 |
| Wagner, G | 1 |
| Hilger, HH | 1 |
| Louven, B | 1 |
| Wagner, J | 1 |
| Hellwig, H | 1 |
2 reviews available for dipyridamole and Abnormality, Heart
| Article | Year |
|---|---|
[Congenital and acquired thrombocyte function disorders].
Topics: Aspirin; Blood Platelet Disorders; Dipyridamole; Fibrin Fibrinogen Degradation Products; Heart Defec | 1980 |
Congenital heart disease: current indications for antithrombotic therapy in pediatric patients.
Topics: Anticoagulants; Child; Dipyridamole; Fontan Procedure; Heart Defects, Congenital; Heart Valve Prosth | 2001 |
11 other studies available for dipyridamole and Abnormality, Heart
| Article | Year |
|---|---|
[REHABILITATION IN HEART DISEASE].
Topics: Acenocoumarol; Dipyridamole; Electrocardiography; Geriatrics; Heart Defects, Congenital; Heart Disea | 1963 |
Imaging of platelets in right-sided extracardiac conduits in humans.
Topics: Adolescent; Adult; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Child; Dipyridamole; Evaluatio | 1982 |
[Inhibition of platelet function in pediatric medicine (author's transl)].
Topics: Age Factors; Aspirin; Child; Dipyridamole; Glomerulonephritis; Graft Rejection; Heart Defects, Conge | 1982 |
CarboMedics valve in congenital heart disease. Midterm follow-up study of 14 patients.
Topics: Aortic Valve; Aspirin; Child; Dipyridamole; Female; Follow-Up Studies; Heart Defects, Congenital; He | 1994 |
The role of anticoagulation in the development of pericardial effusion and late tamponade after cardiac surgery.
Topics: Adult; Anticoagulants; Aspirin; Cardiac Surgical Procedures; Cardiac Tamponade; Coronary Artery Bypa | 1993 |
Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Inhalation; Adolescent; Child, Preschool; Dipyr | 1998 |
Hemodynamic effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
Topics: Administration, Inhalation; Child; Dipyridamole; Heart Defects, Congenital; Hemodynamics; Humans; Hy | 1998 |
[Hamostasiological changes induced by platelet-aggregation-inhibitors, tested in children with congenital heart disease (in vitro and in vitro examinations) (author's transl)].
Topics: Adolescent; Aspirin; Child; Child, Preschool; Cyanosis; Dipyridamole; Heart Defects, Congenital; Hem | 1976 |
Dipyridamole and thrombocyte count in open-heart surgery.
Topics: Adult; Blood Cell Count; Blood Platelets; Cardiopulmonary Bypass; Dipyridamole; Extracorporeal Circu | 1975 |
[Comparative study of the effect of coronary dilating agents on coronary circulation in humans].
Topics: Adolescent; Adult; Blood Pressure; Coronary Vessels; Dipyridamole; Heart Defects, Congenital; Heart | 1969 |
[Influencing the coronary blood flow by blood flow enhancing drugs].
Topics: Adolescent; Adult; Coronary Disease; Dipyridamole; Heart Defects, Congenital; Humans; Middle Aged; V | 1967 |